糖心传媒

This website uses cookies to understand how you use the website and to improve your experience. By continuing to use the website, you accept the 糖心传媒鈥檚 use of cookies and similar technologies. To learn more about our use of cookies and how to manage your browser cookie settings, please review our Privacy Notice.

Amy Deveau presented her research at the Biology, Behavior, and Chemistry: Translational Research in Addiction meeting

Dr. Amy Deveau, associate professor in the Department of Chemistry & Physics, recently presented her research at the Biology, Behavior, and Chemistry: Translational Research in Addiction meeting that was held in San Antonio, Texas from March 4-6, 2011.  Dr. Deveau's talk was titled 鈥淚n Vitro Characterization and In Vivo Blockade Study of Lead Compound LAA-2-27b鈥.  The talk discussed the synthesis and characterization of biologically-active compounds that were created in Dr. Deveau's lab and then their subsequent screening for in vitro biological activity by pharmacologists Dr. Richard Rothman (NIDA/NIH) and Dr. Wolfgang Sadee (Ohio State University) and their colleagues.  The talk further featured results from Dr. Ed Bilsky's lab in UNECOM that studied one compound's ability to reverse morphine's pharmacological effects in mice.  Most importantly, the talk highlighted research done by UNE students Andrea Pelotte (09', BCH/Med Bio), Elizabeth "Liz" Andrews (10', BCH/Med Bio) and Tanya Lawrence (11', Med Bio), as well as contributions by Denise Giuvelis (research associate, Bilsky Lab).  

Liz Andrews, now a graduate student in Chemistry at the University of Hawaii-Manoa, was also awarded a competitive travel stipend to attend the meeting.  Liz presented a separate poster titled "Synthesis, Characterization and Evaluation of Diphenyl and Dimethyl Carbamate Derivatives of 6_-Naltrexol in Vitro and in Vivo as Possible Treatments for Opioid Addiction".